Early research (Phase 1)Study completedNCT01548807
What this trial is testing
Phase 1 Trial of the Mammalian Target of Rapamycin (mTOR) Inhibitor Everolimus Plus Radiation Therapy (RT) for Salvage Treatment of Biochemical Recurrence in Prostate Cancer Patients Following Prostatectomy
Who this might be right for
Prostate Cancer Patients With Detectable PSA Following Prostatectomy
Abramson Cancer Center at Penn Medicine 19